These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32290820)

  • 1. Lifetime risk assessment in cholesterol management among hypertensive patients: observational cross-sectional study based on electronic health record data.
    Tahkola A; Korhonen P; Kautiainen H; Niiranen T; Mäntyselkä P
    BMC Fam Pract; 2020 Apr; 21(1):62. PubMed ID: 32290820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).
    Boytsov S; Logunova N; Khomitskaya Y;
    Cardiovasc Diabetol; 2017 Dec; 16(1):158. PubMed ID: 29246151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cholesterol concentration and prevalence, awareness, treatment, and control of high low-density lipoprotein cholesterol in the Korea National Health and Nutrition Examination Surveys 2008-2010: Beyond the Tip of the Iceberg.
    Lee YH; Lee SG; Lee MH; Kim JH; Lee BW; Kang ES; Lee HC; Cha BS
    J Am Heart Assoc; 2014 Feb; 3(1):e000650. PubMed ID: 24572249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex disparity persists in the prevention of cardiovascular disease in women on statin therapy compared to that in men.
    Moreno-Arellano S; Delgado-de-Mendoza J; Santi-Cano MJ
    Nutr Metab Cardiovasc Dis; 2018 Aug; 28(8):810-815. PubMed ID: 29754716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol goal attainment in hypertensive patients: the impact of metabolic syndrome components.
    Rodrigues CJ; Ribeiro HF; Ribeiro AB; Zanella MT; Batista MC
    Metab Syndr Relat Disord; 2012 Jun; 10(3):195-201. PubMed ID: 22313142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of atorvastatin in achieving National Cholesterol Education Program low-density lipoprotein targets in women with severe dyslipidemia and cardiovascular disease or risk factors for cardiovascular disease: The Women's Atorvastatin Trial on Cholesterol (WATCH).
    McPherson R; Angus C; Murray P; Genest J;
    Am Heart J; 2001 Jun; 141(6):949-56. PubMed ID: 11376309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular Quality of Care Assessment: Clinicians' Adherence to Lipid-Lowering Therapy for Patients with Atherosclerotic Cardiovascular Disease.
    Chan J; Rajalingam T; Fossella J; Zhou H; Eisenberg N; Roche-Nagle G
    Ann Vasc Surg; 2020 Nov; 69():197-205. PubMed ID: 32554202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid attainment among patients newly treated with lipid-altering drugs.
    Hess G; Chang CL; Chung K
    Curr Med Res Opin; 2014 Sep; 30(9):1743-56. PubMed ID: 24889282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment after acute coronary syndrome: a Danish population-based cohort study.
    Kristensen MS; Green A; Nybo M; Hede SM; Mikkelsen KH; Gislason G; Larsen ML; Ersbøll AK
    BMC Cardiovasc Disord; 2020 Jul; 20(1):336. PubMed ID: 32660429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercholesterolemia, eligibility for lipid-lowering therapy and therapeutic success: population-based study in a Portuguese urban population.
    Alves L; Azevedo A
    Eur J Endocrinol; 2008 Dec; 159(6):755-60. PubMed ID: 18796541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Hypercholesterolemia, Appropriateness of Therapeutic Approaches and New Drugs in Patients with High Cardiovascular Risk.
    Agabiti Rosei E; Salvetti M
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):217-30. PubMed ID: 27567901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
    Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A
    Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study in high-risk, maximally pretreated patients to determine the potential use of PCSK9 inhibitors at various thresholds of total and LDL cholesterol levels.
    Groves C; Shetty C; Strange RC; Waldron J; Ramachandran S
    Postgrad Med J; 2017 Apr; 93(1098):205-208. PubMed ID: 27531965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS).
    Danchin N; Almahmeed W; Al-Rasadi K; Azuri J; Berrah A; Cuneo CA; Karpov Y; Kaul U; Kayıkçıoğlu M; Mitchenko O; Ruiz AJ; Aguilar Salinas CA; Santos RD; Mercier F; Blom D;
    Eur J Prev Cardiol; 2018 Jul; 25(10):1087-1094. PubMed ID: 29771156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of a physician-directed treatment program for low-income patients with high blood cholesterol: the Southeast Cholesterol Project.
    Keyserling TC; Ammerman AS; Davis CE; Mok MC; Garrett J; Simpson R
    Arch Fam Med; 1997; 6(2):135-45. PubMed ID: 9075448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare resource utilization in patients on lipid-lowering therapies outside Western Europe and North America: findings of the cross-sectional observational International ChoLesterol management Practice Study (ICLPS).
    Annemans L; Azuri J; Al-Rasadi K; Al-Zakwani I; Daclin V; Mercier F; Danchin N
    Lipids Health Dis; 2020 Apr; 19(1):64. PubMed ID: 32264883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical determinants and treatment gaps in familial hypercholesterolemia: Data from a multi-ethnic regional health service.
    Zafrir B; Jubran A; Lavie G; Halon DA; Flugelman MY; Shapira C
    Eur J Prev Cardiol; 2017 May; 24(8):867-875. PubMed ID: 28186442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing low-density lipoprotein cholesterol target achievement in primary care - Results from DYSIS China.
    Lin X; Xu R; Fang L; Chen W; Hu D; Zhao S; Wang Y; Li J; Yan X;
    Int J Cardiol; 2016 Nov; 222():51-56. PubMed ID: 27454615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial.
    Persell SD; Lloyd-Jones DM; Friesema EM; Cooper AJ; Baker DW
    J Gen Intern Med; 2013 Apr; 28(4):554-60. PubMed ID: 23143672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of atherosclerosis detection by carotid ultrasound on physician behavior and risk-factor management in asymptomatic hypertensive subjects.
    Hong SJ; Chang HJ; Song K; Hong GR; Park SW; Kang HJ; Kim EJ; Kim DS; Jeong MH
    Clin Cardiol; 2014 Feb; 37(2):91-6. PubMed ID: 24193449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.